vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and SILVERCORP METALS INC (SVM). Click either name above to swap in a different company.
SILVERCORP METALS INC is the larger business by last-quarter revenue ($223.8M vs $151.7M, roughly 1.5× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -1.3%, a 9.1% gap on every dollar of revenue. Over the past eight quarters, SILVERCORP METALS INC's revenue compounded faster (87.6% CAGR vs 50.0%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Silvercorp Metals Inc. (Silvercorp) is a Canadian-based, China-focused precious metals company engaged in the acquisition, exploration, and development of silver-containing properties.
NUTX vs SVM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $223.8M |
| Net Profit | $11.8M | $-2.9M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | — |
| Net Margin | 7.8% | -1.3% |
| Revenue YoY | -41.1% | — |
| Net Profit YoY | -80.8% | — |
| EPS (diluted) | $2.34 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $223.8M | ||
| Q3 25 | $267.8M | — | ||
| Q2 25 | $244.0M | $72.2M | ||
| Q1 25 | $211.8M | — | ||
| Q4 24 | $257.6M | $172.5M | ||
| Q3 24 | $78.8M | $114.0M | ||
| Q2 24 | $76.1M | $60.0M | ||
| Q1 24 | $67.5M | — |
| Q4 25 | $11.8M | $-2.9M | ||
| Q3 25 | $55.4M | — | ||
| Q2 25 | $-17.7M | $28.1M | ||
| Q1 25 | $21.2M | — | ||
| Q4 24 | $61.6M | $42.1M | ||
| Q3 24 | $-8.8M | $28.0M | ||
| Q2 24 | $-364.0K | $13.2M | ||
| Q1 24 | $-364.0K | — |
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
| Q4 25 | 20.4% | — | ||
| Q3 25 | 48.7% | — | ||
| Q2 25 | 13.8% | — | ||
| Q1 25 | 38.1% | — | ||
| Q4 24 | 44.4% | 30.5% | ||
| Q3 24 | 12.3% | 30.7% | ||
| Q2 24 | 7.0% | 30.0% | ||
| Q1 24 | 2.1% | — |
| Q4 25 | 7.8% | -1.3% | ||
| Q3 25 | 20.7% | — | ||
| Q2 25 | -7.3% | 39.0% | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 23.9% | 24.4% | ||
| Q3 24 | -11.2% | 24.5% | ||
| Q2 24 | -0.5% | 22.0% | ||
| Q1 24 | -0.5% | — |
| Q4 25 | $2.34 | — | ||
| Q3 25 | $7.76 | — | ||
| Q2 25 | $-2.95 | — | ||
| Q1 25 | $3.33 | — | ||
| Q4 24 | $11.56 | — | ||
| Q3 24 | $-1.72 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | — |
| Total Assets | $918.5M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | — | ||
| Q3 25 | $166.0M | — | ||
| Q2 25 | $96.7M | — | ||
| Q1 25 | $84.7M | — | ||
| Q4 24 | $40.6M | — | ||
| Q3 24 | $46.9M | — | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | $30.0M | — |
| Q4 25 | $329.4M | — | ||
| Q3 25 | $317.2M | — | ||
| Q2 25 | $235.3M | — | ||
| Q1 25 | $176.9M | — | ||
| Q4 24 | $132.4M | — | ||
| Q3 24 | $60.4M | — | ||
| Q2 24 | $62.7M | — | ||
| Q1 24 | $63.0M | — |
| Q4 25 | $918.5M | — | ||
| Q3 25 | $964.5M | — | ||
| Q2 25 | $841.0M | — | ||
| Q1 25 | $761.9M | — | ||
| Q4 24 | $655.3M | — | ||
| Q3 24 | $438.5M | — | ||
| Q2 24 | $422.4M | — | ||
| Q1 24 | $404.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $107.9M |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $107.9M | ||
| Q3 25 | $99.5M | — | ||
| Q2 25 | $27.3M | $40.0M | ||
| Q1 25 | $51.0M | — | ||
| Q4 24 | $54.0K | $81.3M | ||
| Q3 24 | $6.8M | $57.7M | ||
| Q2 24 | $13.3M | $28.9M | ||
| Q1 24 | $3.1M | — |
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | $33.8M | ||
| Q2 24 | $12.7M | $17.0M | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | 29.6% | ||
| Q2 24 | 16.7% | 28.3% | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | 21.0% | ||
| Q2 24 | 0.7% | 19.8% | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | 1.93× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 2.19× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
SVM
Segment breakdown not available.
